Halo Genomics AB

Dag Hammarskjölds väg 54A,
Uppsala, 751 83
Sweden,

Halo Genomics is a provider of technology for the next-generation DNA sequencing market. Halo Genomics' technology addresses sequence-selective sample preparation in next-generation sequencing. The company's HaloPlex technology combines the speed and specificity of polymerase chain reaction-based systems with the scalability and capture-size flexibility of solution-based hybridization formats, thus eliminating the need for library preparation.

Halo Genomics AB was acquired by Agilent Technologies on December 01, 2011.

Join Mergr to view all 162 acquisitions of life science companies in 2011, including 18 acquisitions by private equity firms, and 144 by strategics.

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view this profile - and discover more life science acquisitions of companies like Halo Genomics AB.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.1K Private Equity Firms
  • 110K M&A Transactions
  • 120K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.